Register
Register
Register

Oliveira Mona

CEO

BioLinker

Cotia, Brazil

3 profile visitsTechnology solution provider

Entrepreneur, scientist, mom of 2. CEO of BioLinker, merging AI & biology to create breakthrough proteins for global biotech.

My organisation

BioLinker

BioLinker

Startup / Scaleup

Cotia, Brazil

BioLinker is a São Paulo‑based synthetic biology powerhouse, engineering next‑generation proteins via AI-driven platforms. As the first Latin American company to provide cell‑free systems for complex protein expression, BioLinker serves Fortune 500 clients and specializes in hard‑to‑express proteins for pharma, agriculture, diagnostics, and industrial biotech. Website Their proprietary Sol platform offers modular, scalable protein engineering—blending in‑silico design, cell‑free and cell‑based systems, directed evolution, and purification pipelines. In 2022, BioLinker gained recognition for developing a rapid SARS‑CoV‑2 self‑test—producing all reagents locally in São Paulo, supported by FAPESP’s PIPE program, with 15‑minute home results across all variants agencia.fapesp.br. The company has also been featured at scientific article at PubMed as recent publication Antigen Awards & recognition: Top 500 DeepTech Startup (Hello Tomorrow), Top 3 Biotech Startup in Brazil (100 Open Startups), Sebrae “Startup of the Future”, Top 40 at Wolves Summit, USP Alumni Award for Innovation & Entrepreneurship .
Read more

About me

Dr. Mona Oliveira holds a degree in Veterinary Medicine, a Master’s in Biotechnology, and a dual PhD between Brazil and Slovenia. With over 15 years of experience in applied biosciences, she founded BioLinker eight years ago, now a leading synthetic biology company in Latin America. As CEO, she is pioneering breakthrough technologies at the intersection of science, innovation, and AI—advancing the next generation of protein engineering.

She has been recognized with multiple national and international awards, including the USP Alumni Award for Innovation and Entrepreneurship, the Women Innovators Award from FINEP, and Top 3 finalist at the Harvard University Brazil Conference Startup Competition (2024). She also won 2nd place at Web Summit Rio (2023) and was ranked among Brazil’s Top 3 Biotech Startups by 100 Open Startups (2023).

A passionate scientist, entrepreneur, mother of two, and wife, she is committed to building BioLinker into Latin America's largest synthetic biology platform—driving scientific excellence, sustainability, and global impact.

Social media

Skills

  • Sales
  • Negotiantion
  • patents
  • grants

Interests

  • Networks
  • Service Provider
  • Adviser
  • Investor

International markets of interest

Make a selection from the list provided:

BrazilChina

Marketplace (3)

  • Service

    Protein on demand

    Custom proteins on demand—designed, expressed, and delivered using AI and synthetic biology for research, diagnostics, or industry.

    • Research & Development
    Author

    Oliveira Mona

    CEO at BioLinker

    Cotia, Brazil

  • Product

    InvitroLinker

    InvitroLinker boosts swine sperm viability by up to 70%—a protein-based additive for more efficient artificial insemination.

    • Buyer
    • Commercial agent
    • Re-Seller/Wholesaler
    • Biotech, Pharma and Cosmetics
    Author

    Oliveira Mona

    CEO at BioLinker

    Cotia, Brazil

  • Investment

    Seed Investment

    BioLinker seeks seed investment to scale its synbio platform and launch high-impact biotech solutions like InvitroLinker.

    • Seed and Development
    • Biotech, Pharma and Cosmetics
    Author

    Oliveira Mona

    CEO at BioLinker

    Cotia, Brazil